EndoRel Biosciences

Business Services · Oregon, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2828 S Corbett Ave, Portland, Oregon, 97...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About EndoRel Biosciences

EndoRel Biosciences is focused on advancing intracellular therapeutics through the commercialization of a novel peptide-based technology that enhances cytosolic delivery for RNA therapeutics and other biomacromolecules. The company addresses the challenge of delivering drugs to the cytosol, which is crucial for the efficacy of RNA-based treatments. By improving cytosolic delivery, EndoRel aims to develop safer and more effective drugs, ultimately benefiting patients. Their innovative approach targets the significant issue of poor drug delivery that hinders the potential of promising therapeutics.Explore more
EndoRel Biosciences's Social MediaPopular SearchesEndoRel BiosciencesSIC Code 87,873NAICS Code 54,541Show more

EndoRel Biosciences Org Chart

PhoneEmail
JB
United States flag for contact location.

Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is EndoRel Biosciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to EndoRel Biosciences

Compare insights from companies similar to EndoRel Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

EndoRel Biosciences

<$5M
1-10
Private
-
2021
<$5M
11-50
Private
<$5M
2016
BS
Brandon SandPrincipal Scientist
<$5M
1-10
Private
$70.4M
2009
Simon Harnest, Chief Financial Officer at ProLynx
Simon HarnestChief Financial Officer
<$5M
1-10
Private
-
2015
JL
Jun LiPrincipal Investigator
<$5M
1-10
Private
<$5M
2018
Bob Prud'homme, Co-Founder & Chief Technology Officer at Optimeos Life Sciences
Bob Prud'hommeCo-Founder & Chief Technology Officer
<$5M
1-10
Private
-
2012
LN
Liliane NguyenManager, Business
<$5M
1-10
Private
<$5M
2018
JW
Jason WojcechowskyjDirector of Vaccines
Illustration of an envelope

EndoRel Biosciences Tech Stack

A closer look at the technologies used by EndoRel Biosciences

Top Business Services Companies

Frequently Asked Questions Regarding EndoRel Biosciences

What is EndoRel Biosciences's official website?
EndoRel Biosciences's official website is www.endorelbio.com
What is EndoRel Biosciences's Revenue?
EndoRel Biosciences's revenue is <$5 Million
What is EndoRel Biosciences's SIC code?
EndoRel Biosciences's SIC: 87,873
What is EndoRel Biosciences's NAICS code?
EndoRel Biosciences's NAICS: 54,541
How many employees does EndoRel Biosciences have?
EndoRel Biosciences has 1-10 employees
What industry does EndoRel Biosciences belong to?
EndoRel Biosciences is in the industry of: Business Services, Research & Development
What is EndoRel Biosciences competition?
EndoRel Biosciences top competitors include: Zy Therapeutics, ProLynx, Dyve Biosciences, Optimeos Life Sciences
What technology does EndoRel Biosciences use?
Some of the popular technologies that EndoRel Biosciences uses are: reCAPTCHA, Google Font API, jQuery
What does EndoRel Biosciences do?

EndoRel Biosciences is focused on advancing intracellular therapeutics through the commercialization of a novel peptide-based technology that enhances cytosolic delivery for RNA therapeutics and other biomacromolecules. The company addresses the challenge of delivering drugs to the cytosol, which is crucial for the efficacy of RNA-based treatments.... By improving cytosolic delivery, EndoRel aims to develop safer and more effective drugs, ultimately benefiting patients. Their innovative approach targets the significant issue of poor drug delivery that hinders the potential of promising therapeutics.Read More

What are EndoRel Biosciences social media links?
EndoRel Biosciences Linkedin page
Is EndoRel Biosciences a public company?
EndoRel Biosciences is private company therefore does not currently have an official ticker symbol
See more information about EndoRel Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.